Uncategorized
Zio Demand Drives 20% Revenue Growth For iRhythm, Bullish Sentiment Builds Among Analysts
iRhythm raises 2025 sales forecast and launches Zio ECG system in Japan as analysts boost ratings and price targets on strong Q1 performance. Latest Ratings for IRTC Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Needham Upgrades Hold Buy Jan 2022 JP Morgan Maintains Overweight View More Analyst Ratings for…
New MST ETF Mixes MicroStrategy (Strategy) Leverage With A Side Of Weekly Income
Defiance ETFs introduces Defiance Leveraged Long + Income MSTR ETF, combining leveraged exposure to MicroStrategy (Strategy) stock with weekly income for risk-tolerant investors. read more
Wall Street Eyes 9th Straight Day Of Gains, Apple Falls As Chinese Sales Disappoint: What’s Driving Markets Friday?
U.S. stocks advanced across the board by midday Friday, with the S&P 500 eyeing its ninth consecutive day of gains—poised for the longest winning streak since May 2024. read more
What’s Going On With Altimmune (ALT) Stock Today?
Altimmune shares jumped 8.5% on Friday. The stock is higher ahead of next week’s presentation at the European Association for the Study of the Liver International Liver Congress. read more
What’s Going On With Reddit Shares Friday?
Reddit reported better-than-expected first-quarter earnings on Thursday after the market closed. read more
